Expert Opinion on Pharmacotherapy, Volume 23, Issue 13 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 23, Issue 13 (2022)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Volume 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?
Fiammetta Vanoli & Renato Mantegazza
Pages: 1471-1474
Published online: 14 Sep 2022
First Page PreviewforWhat are the pharmacotherapeutic considerations for the treatment of myasthenia gravis? | Full Text | References | PDF (200.9 KB) | EPUB
  • 2178 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Clinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments
David Staskin
Pages: 1475-1477
Published online: 31 Aug 2022
First Page PreviewforClinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments | Full Text | References | PDF (154.4 KB) | EPUB
  • 910 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
Vibegron for the treatment of overactive bladder: a comprehensive update
Stephanie Gleicher, Elisabeth M. Sebesta, W. Stuart Reynolds & Roger Dmochowski
Pages: 1479-1484
Published online: 21 Sep 2022
AbstractforVibegron for the treatment of overactive bladder: a comprehensive update | Full Text | References | PDF (203.3 KB) | EPUB
  • 224 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
An evaluation of long-acting cabotegravir + rilpivirine for the treatment of virologically suppressed adults living with HIV
Hamdi Qazzaz, Christopher Parganas & Theodore James Cory
Pages: 1485-1495
Published online: 20 Sep 2022
AbstractforAn evaluation of long-acting cabotegravir + rilpivirine for the treatment of virologically suppressed adults living with HIV | Full Text | References | PDF (398.1 KB) | EPUB
  • 178 Views
  • 1 CrossRef citations
  • 0Altmetric

Special Report

Article
Dual sodium-glucose cotransporter (SGLT) 1/2 versus pure SGLT2 inhibitors: two distinct drug categories or one class with multiple faces?
Theocharis Koufakis, Michael Doumas, Pantelis Zebekakis & Kalliopi Kotsa
Pages: 1497-1502
Published online: 17 Aug 2022
AbstractforDual sodium-glucose cotransporter (SGLT) 1/2 versus pure SGLT2 inhibitors: two distinct drug categories or one class with multiple faces? | Full Text | References | PDF (201.7 KB) | EPUB
  • 190 Views
  • 1 CrossRef citations
  • 0Altmetric

Perspective

Article
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4
Sven G Meuth, Antonios Bayas, Boris Kallmann, Ralf Linker, Peter Rieckmann, Mike P Wattjes, Mathias Mäurer & Christoph Kleinschnitz
Pages: 1503-1510
Published online: 05 Aug 2022
AbstractforLong-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4 | Full Text | References | PDF (3.2 MB) | EPUB
  • 6073 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Review

Review
Pharmacotherapeutic management of seizures in patients with Angleman Syndrome
Debopam Samanta
Pages: 1511-1522
Published online: 26 Jul 2022
AbstractforPharmacotherapeutic management of seizures in patients with Angleman Syndrome | Full Text | References | PDF (385.2 KB) | EPUB
  • 238 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Current and emerging pharmacotherapeutic strategies for Tourette syndrome
Andrea E. Cavanna
Pages: 1523-1533
Published online: 01 Aug 2022
AbstractforCurrent and emerging pharmacotherapeutic strategies for Tourette syndrome | Full Text | References | PDF (366.8 KB) | EPUB
  • 2420 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Review
Advances in the pharmacological management of acute myeloid leukemia in adults
Yazan Numan, Yasmin Abaza, Jessica K Altman & Leonidas C Platanias
Pages: 1535-1543
Published online: 07 Sep 2022
AbstractforAdvances in the pharmacological management of acute myeloid leukemia in adults | Full Text | References | PDF (322.6 KB) | EPUB
  • 257 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Approved and emerging Bruton’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia
Alycia Hatashima, Mehdi Karami & Mazyar Shadman
Pages: 1545-1557
Published online: 22 Aug 2022
AbstractforApproved and emerging Bruton’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia | Full Text | References | PDF (1.7 MB) | EPUB
  • 229 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Rizwana Parveen et al.
Review Article | Published online: 28 May 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña et al.
Review Article | Published online: 28 May 2024
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska et al.
Review Article | Published online: 27 May 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Review Article | Published online: 27 May 2024
View all latest articles